{"id":253114,"date":"2018-08-13T13:00:09","date_gmt":"2018-08-13T13:00:09","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=253114"},"modified":"2018-08-13T13:00:09","modified_gmt":"2018-08-13T13:00:09","slug":"biologics-outsourcing-global-market-analysis-growth-opportunities-top-key-players-and-forecast-to-2025","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/biologics-outsourcing-global-market-analysis-growth-opportunities-top-key-players-and-forecast-to-2025_253114.html","title":{"rendered":"Biologics Outsourcing Global Market Analysis, Growth, Opportunities, Top Key Players and Forecast to 2025"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Biologics Outsourcing Market”<\/div>\n<\/div>\n<\/div>\n
WiseGuyRerports.com Presents \u201cGlobal Biologics Outsourcing Market Size, Status and Forecast 2025\u201d New Document to its Studies Database<\/div>\n

 <\/p>\n

This report studies the global Biologics Outsourcing<\/a><\/strong> market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Biologics Outsourcing market by companies, region, type and end-use industry.<\/p>\n

Outsourcing is increasing as a percentage of the whole manufacturing capacity due to relatively more of new product manufacturing is outsourced and facilities with products that become generic are non-core and are being divested. 
In 2017, the global Biologics Outsourcing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.<\/p>\n

This report focuses on the global top players<\/strong>, covered 
Boehringer Ingelheim 
Catalent 
GenScript 
Innovent Biologics 
Syngene 
Shanghai Medicilon 
GL Biochem Corporation 
GVK Biosciences Private 
Horizon Discovery Group 
Innovent Biologics 
Selexis 
Lonza 
Abzena 
Adimab<\/strong><\/p>\n

 <\/p>\n

 Request For Sample Report<\/strong> @ https:\/\/www.wiseguyreports.com\/sample-request\/3328910-global-biologics-outsourcing-market-size-status-and-forecast-2025<\/a>                       <\/p>\n

                                     <\/p>\n

Market segment by Regions\/Countries<\/strong>, this report covers 
United States 
Europe 
China 
Japan 
Southeast Asia 
India<\/p>\n

Market segment by Type,<\/strong> the product can be split into 
Antibody 
Recombinant 
Protein 
Vaccines 
Others<\/p>\n

Market segment by Application<\/strong>, split into 
Vaccine & Therapeutics Development 
Blood & Blood Related Products Testing 
Cellular and Gene Therapy 
Other<\/p>\n

The study objectives of this report are: 
<\/strong>To study and forecast the market size of Biologics Outsourcing in global market. 
To analyze the global key players, SWOT analysis, value and global market share for top players. 
To define, describe and forecast the market by type, end use and region. 
To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World. 
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks. 
To identify significant trends and factors driving or inhibiting the market growth. 
To analyze the opportunities in the market for stakeholders by identifying the high growth segments. 
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market 
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market 
To strategically profile the key players and comprehensively analyze their growth strategies.<\/p>\n

 <\/strong><\/p>\n

Complete Report Details @ <\/strong>https:\/\/www.wiseguyreports.com\/reports\/3328910-global-biologics-outsourcing-market-size-status-and-forecast-2025<\/a>               <\/p>\n

 <\/p>\n

Table Of Contents:      <\/strong><\/p>\n

1 Industry Overview of Biologics Outsourcing 
1.1 Biologics Outsourcing Market Overview 
<\/strong>1.1.1 Biologics Outsourcing Product Scope 
1.1.2 Market Status and Outlook 
1.2 Global Biologics Outsourcing Market Size and Analysis by Regions (2013-2018) 
<\/strong>1.2.1 United States 
1.2.2 Europe 
1.2.3 China 
1.2.4 Japan 
1.2.5 Southeast Asia 
1.2.6 India 
1.3 Biologics Outsourcing Market by Type 
<\/strong>1.3.1 Antibody 
1.3.2 Recombinant 
1.3.3 Protein 
1.3.4 Vaccines 
1.3.5 Others 
1.4 Biologics Outsourcing Market by End Users\/Application 
<\/strong>1.4.1 Vaccine & Therapeutics Development 
1.4.2 Blood & Blood Related Products Testing 
1.4.3 Cellular and Gene Therapy 
1.4.4 Other<\/p>\n

2 Global Biologics Outsourcing Competition Analysis by Players 
<\/strong>2.1 Biologics Outsourcing Market Size (Value) by Players (2013-2018) 
2.2 Competitive Status and Trend 
2.2.1 Market Concentration Rate 
2.2.2 Product\/Service Differences 
2.2.3 New Entrants 
2.2.4 The Technology Trends in Future<\/p>\n

3 Company (Top Players) Profiles 
3.1 Boehringer Ingelheim 
<\/strong>3.1.1 Company Profile 
3.1.2 Main Business\/Business Overview 
3.1.3 Products, Services and Solutions 
3.1.4 Biologics Outsourcing Revenue (Million USD) (2013-2018) 
3.2 Catalent 
<\/strong>3.2.1 Company Profile 
3.2.2 Main Business\/Business Overview 
3.2.3 Products, Services and Solutions 
3.2.4 Biologics Outsourcing Revenue (Million USD) (2013-2018) 
3.3 GenScript 
<\/strong>3.3.1 Company Profile 
3.3.2 Main Business\/Business Overview 
3.3.3 Products, Services and Solutions 
3.3.4 Biologics Outsourcing Revenue (Million USD) (2013-2018) 
3.4 Innovent Biologics 
<\/strong>3.4.1 Company Profile 
3.4.2 Main Business\/Business Overview 
3.4.3 Products, Services and Solutions 
3.4.4 Biologics Outsourcing Revenue (Million USD) (2013-2018) 
3.5 Syngene 
<\/strong>3.5.1 Company Profile 
3.5.2 Main Business\/Business Overview 
3.5.3 Products, Services and Solutions 
3.5.4 Biologics Outsourcing Revenue (Million USD) (2013-2018) 
3.6 Shanghai Medicilon 
<\/strong>3.6.1 Company Profile 
3.6.2 Main Business\/Business Overview 
3.6.3 Products, Services and Solutions 
3.6.4 Biologics Outsourcing Revenue (Million USD) (2013-2018) 
3.7 GL Biochem Corporation 
<\/strong>3.7.1 Company Profile 
3.7.2 Main Business\/Business Overview 
3.7.3 Products, Services and Solutions 
3.7.4 Biologics Outsourcing Revenue (Million USD) (2013-2018) 
3.8 GVK Biosciences Private 
<\/strong>3.8.1 Company Profile 
3.8.2 Main Business\/Business Overview 
3.8.3 Products, Services and Solutions 
3.8.4 Biologics Outsourcing Revenue (Million USD) (2013-2018) 
3.9 Horizon Discovery Group 
<\/strong>3.9.1 Company Profile 
3.9.2 Main Business\/Business Overview 
3.9.3 Products, Services and Solutions 
3.9.4 Biologics Outsourcing Revenue (Million USD) (2013-2018) 
3.10 Innovent Biologics 
<\/strong>3.10.1 Company Profile 
3.10.2 Main Business\/Business Overview 
3.10.3 Products, Services and Solutions 
3.10.4 Biologics Outsourcing Revenue (Million USD) (2013-2018) 
3.11 Selexis 
3.12 Lonza 
3.13 Abzena 
3.14 Adimab<\/strong><\/p>\n

 Continued…….<\/strong>                                                  <\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Wiseguyreports.com
Contact Person:<\/strong> Norah Trent
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9349, +44 208 133 9349
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.wiseguyreports.com<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Biologics Outsourcing Market” WiseGuyRerports.com Presents \u201cGlobal Biologics Outsourcing Market Size, Status and Forecast 2025\u201d New Document to its Studies Database   This report studies the global Biologics Outsourcing market size, industry status and forecast, competition landscape and growth opportunity. This … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-253114","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/253114","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=253114"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/253114\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=253114"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=253114"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=253114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}